{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:19:15Z","timestamp":1790176755153,"version":"4.1.0"},"reference-count":185,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jinf.2014.06.006","type":"journal-article","created":{"date-parts":[[2014,6,23]],"date-time":"2014-06-23T01:30:57Z","timestamp":1403487057000},"page":"309-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":158,"title":["Review: Current and new generation pneumococcal vaccines"],"prefix":"10.1016","volume":"69","author":[{"given":"Charles","family":"Feldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2014.06.006_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.idc.0000121024.62151.c9","article-title":"Pneumococcal disease. Pathogenesis, treatment, and prevention","volume":"12","author":"McDaniel","year":"2004","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.jinf.2014.06.006_bib2","doi-asserted-by":"crossref","first-page":"490346","DOI":"10.1155\/2013\/490346","article-title":"Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease","volume":"2013","author":"Steel","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jinf.2014.06.006_bib3","doi-asserted-by":"crossref","first-page":"e1000476","DOI":"10.1371\/journal.ppat.1000476","article-title":"Pneumococcal capsular polysaccharide structure predicts serotype prevalence","volume":"5","author":"Weinberger","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jinf.2014.06.006_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.82.6.445","article-title":"Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides","volume":"82","author":"Macleod","year":"1945","journal-title":"J Exp Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1183\/09059180.00008911","article-title":"The remaining challenges of pneumococcal disease in adults","volume":"21","author":"Ludwig","year":"2012","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jinf.2014.06.006_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1469-0691.2012.03937.x","article-title":"Understanding the burden of pneumococcal disease in adults","volume":"18","author":"Blasi","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2014.06.006_bib7","doi-asserted-by":"crossref","first-page":"e60273","DOI":"10.1371\/journal.pone.0060273","article-title":"AGEDD Adult Pneumococcal Burden Study Team. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques","volume":"8","author":"Said","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2014.06.006_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/1469-0691.12461","article-title":"Pneumococcal infection in adults: burden of disease","volume":"20","author":"Drijkoningen","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2014.06.006_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40266-013-0060-5","article-title":"Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice","volume":"30","author":"Villa-Corcoles","year":"2013","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jinf.2014.06.006_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0029-1202938","article-title":"Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention","volume":"30","author":"Lynch","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1055\/s-0032-1315634","article-title":"Microbiology and risk factors for community-acquired pneumonia","volume":"33","author":"Sanz Herrero","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10096-012-1778-4","article-title":"The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis","volume":"32","author":"Rozenbaum","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3810\/pgm.2010.03.2130","article-title":"Burden of community-acquired pneumonia in North American adults","volume":"122","author":"File","year":"2010","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib14","first-page":"108","article-title":"Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region","volume":"38","author":"Song","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2014.06.006_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","article-title":"Clinical and economic burden of community-acquired pneumonia among adults in Europe","volume":"67","author":"Welte","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2014.06.006_bib16","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.vaccine.2011.02.088","article-title":"Healthcare utilization and cost of pneumococcal disease in the United States","volume":"29","author":"Huang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib17","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2014.06.006_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-0029-1202939","article-title":"Streptococcus penumoniae: does antimicrobial resistance matter?","volume":"30","author":"Lynch","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1469-0691.2010.03182.x","article-title":"Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period","volume":"16","author":"Li\u00f1ares","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2014.06.006_bib20","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.medmal.2012.04.003","article-title":"Pneumococcal infections and adult with risk factors","volume":"42","author":"Chidiac","year":"2012","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.jinf.2014.06.006_bib21","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/infdis\/jis240","article-title":"Aging population and future burden of pneumococcal pneumonia in the United States","volume":"205","author":"Wroe","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib22","series-title":"Pneumococcal vaccination: who needs it? Vaccines and immunizations","year":"2014"},{"key":"10.1016\/j.jinf.2014.06.006_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/thoraxjnl-2012-203106","article-title":"Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia","volume":"68","author":"Naucler","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2014.06.006_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/00365540903418522","article-title":"Determinants of outcome in patients with bacteraemic pneumococcal pneumonia: importance of early adequate treatment","volume":"42","author":"Garnacho-Montero","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib25","series-title":"Pneumococcal vaccination in adults","author":"Musher","year":"2013"},{"key":"10.1016\/j.jinf.2014.06.006_bib26","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2165\/11209330-000000000-00000","article-title":"Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): in older adults","volume":"72","author":"Sanford","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.jinf.2014.06.006_bib27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s40266-012-0017-0","article-title":"Pneumococcal polysaccharide conjugate vaccine (13- valent, adsorbed): a guide to its use in older adults","volume":"29","author":"Scott","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jinf.2014.06.006_bib28","first-page":"1102","article-title":"Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23)","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jinf.2014.06.006_bib29","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jinf.2014.06.006_bib30","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1086\/592691","article-title":"Pneumococcal vaccination of elderly adults: new paradigms for protection","volume":"47","author":"Jackson","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1468-1293.2010.00892.x","article-title":"The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review","volume":"12","author":"Pedersen","year":"2011","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib32","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1586\/erv.11.99","article-title":"Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe","volume":"10","author":"Fedson","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jinf.2014.06.006_bib33","first-page":"78","article-title":"Pneumococcal vaccination in adults: rationale, state of the art and perspectives","volume":"53","author":"Icardi","year":"2012","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.jinf.2014.06.006_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.idc.2012.11.011","article-title":"How effective is vaccination in preventing pneumococcal disease?","volume":"27","author":"Musher","year":"2013","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jinf.2014.06.006_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1503\/cmaj.080734","article-title":"Efficacy of pneumococcal vaccination in adults: a meta-analysis","volume":"180","author":"Huss","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.jinf.2014.06.006_bib36","first-page":"CD000422","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"1","author":"Moberley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jinf.2014.06.006_bib37","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/cid\/ciu002","article-title":"Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population ages \u226560 years: 3 years of follow-up in the CAPAMIS study","volume":"58","author":"Ochoa-Gondar","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib38","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.vaccine.2014.02.048","volume":"32","author":"Wiemken","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0264-410X(03)00521-8","article-title":"Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia","volume":"22","author":"T\u00f6rling","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib40","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/infdis\/jir750","article-title":"Hyporesponsiveness following booster immunization with bacterial polysaccharides is caused by apoptosis of memory B cells","volume":"205","author":"Brynjolfsson","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib41","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1016\/j.vaccine.2008.07.071","article-title":"Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency","volume":"26","author":"Schenkein","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJMoa1209165","article-title":"U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination","volume":"369","author":"Griffin","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/cid\/cis359","article-title":"Pneumococcal conjugate vaccine for adults: a new paradigm","volume":"55","author":"Paradiso","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib45","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1016\/j.vaccine.2013.04.085","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-na\u00efve adults","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib46","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1016\/j.vaccine.2013.04.084","article-title":"Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib47","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.vaccine.2014.02.002","article-title":"Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-na\u00efve adults 60\u201364 years of age","volume":"32","author":"Greenberg","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib48","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.vaccine.2013.05.010","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib49","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJMoa0903029","article-title":"A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults","volume":"362","author":"French","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib50","first-page":"378","article-title":"Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults","volume":"66","author":"Hak","year":"2008","journal-title":"Neth J Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib51","unstructured":"http:\/\/www.empr.com\/detailed-data-from-prevnar-13-capita-study-released\/article\/337871\/[last accessed 9 May 2014]."},{"key":"10.1016\/j.jinf.2014.06.006_bib52","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.2012.169","article-title":"Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine","volume":"307","author":"Smith","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2014.06.006_bib53","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1016\/j.vaccine.2013.06.037","article-title":"Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults","volume":"31","author":"Smith","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.amepre.2012.11.035","article-title":"Modeling of cost effectiveness of pneumococcal conjugate vaccination strategies in U.S. older adults","volume":"44","author":"Smith","year":"2013","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib55","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1016\/j.vaccine.2012.05.076","article-title":"Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults ages >50 years","volume":"30","author":"Weycker","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib56","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.vaccine.2014.02.008","article-title":"Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults?","volume":"32","author":"Weil-Olivier","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40273-013-0113-y","article-title":"Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies","volume":"32","author":"Van de Vooren","year":"2014","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jinf.2014.06.006_bib58","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib59","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2014.06.006_bib60","doi-asserted-by":"crossref","first-page":"e1001517","DOI":"10.1371\/journal.pmed.1001517","article-title":"Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites","volume":"10","author":"Feikin","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib61","first-page":"101","article-title":"23-Valent pneumococcal polysaccharide vaccine (PPV23) for the prevention of invasive pneumococcal diseases (IPDs) in the elderly: is it really effective?","volume":"53","author":"Cadeddu","year":"2012","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.jinf.2014.06.006_bib62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/infdis\/jit139","article-title":"The immune response to pneumococcal polysaccharides 14 and 23F among elderly individuals consists predominantly of switched memory B cells","volume":"208","author":"Leggat","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib63","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4103\/2319-4170.104409","article-title":"Lessons learnt after the introduction of the seven valent-pneumococcal conjugate vaccine toward broader spectrum conjugate vaccines","volume":"35","author":"Falup-Pecurariu","year":"2012","journal-title":"Biomed J"},{"key":"10.1016\/j.jinf.2014.06.006_bib64","first-page":"337","article-title":"New trends in the prevention and management of community-acquired pneumonia","volume":"70","author":"Postma","year":"2012","journal-title":"Neth J Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib65","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1007\/s00018-012-1234-8","article-title":"Serotype-independent pneumococcal vaccines","volume":"70","author":"Miyaji","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jinf.2014.06.006_bib66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4161\/hv.18432","article-title":"Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals","volume":"8","author":"Nunes","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jinf.2014.06.006_bib67","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3201\/eid2002.131220","article-title":"Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children","volume":"20","author":"Biesbroek","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib68","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chom.2011.01.007","article-title":"T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization","volume":"9","author":"Moffitt","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jinf.2014.06.006_bib69","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1073\/pnas.1121383109","article-title":"Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity","volume":"109","author":"Malley","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jinf.2014.06.006_bib70","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/imm.12194","article-title":"Prediction and characterization of helper T-cell epitopes from pneumococcal surface adhesin A","volume":"141","author":"Singh","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.jinf.2014.06.006_bib71","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1016\/j.vaccine.2013.06.097","article-title":"Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children","volume":"31","author":"Ditse","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1358\/dot.2011.47.3.1556471","article-title":"New conjugate vaccines for the prevention of pneumococcal disease in developing countries","volume":"47","author":"Ginsburg","year":"2011","journal-title":"Drugs Today"},{"key":"10.1016\/j.jinf.2014.06.006_bib73","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/652006","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy","volume":"201","author":"Dagan","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib74","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jpeds.2010.04.071","article-title":"Serotype-specific hyporesponsiveness to pneumococcal conjugate vaccine in infants carrying pneumococcus at the time of vaccination","volume":"157","author":"V\u00e4kev\u00e4inen","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.jinf.2014.06.006_bib75","doi-asserted-by":"crossref","first-page":"6994","DOI":"10.1016\/j.vaccine.2011.07.035","article-title":"Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization","volume":"29","author":"Madhi","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib76","doi-asserted-by":"crossref","first-page":"e3244","DOI":"10.1371\/journal.pone.0003244","article-title":"Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population","volume":"3","author":"Temime","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2014.06.006_bib77","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/infdis\/jis703","article-title":"Pneumococcal capsular switching: a historical perspective","volume":"207","author":"Wyres","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib78","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1016\/j.vaccine.2011.09.078","article-title":"Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model","volume":"29","author":"Skinner","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib79","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1378\/chest.12-0210","article-title":"Pneumococcal pneumonia: mechanisms of infection and resolution","volume":"142","author":"Dockrell","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2014.06.006_bib80","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/QCO.0b013e3283608419","article-title":"Current concepts in host-microbe interaction leading to pneumococcal pneumonia","volume":"26","author":"Vernatter","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib81","doi-asserted-by":"crossref","first-page":"e26587","DOI":"10.1371\/journal.pone.0026587","article-title":"Changes in serotype alter the surface exposure of pneumococcal adhesins and impact virulence","volume":"6","author":"Sanchez","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2014.06.006_bib82","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.micpath.2007.02.003","article-title":"E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae","volume":"42","author":"Anderton","year":"2007","journal-title":"Microb Pathog"},{"key":"10.1016\/j.jinf.2014.06.006_bib83","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0092-8674(00)00071-4","article-title":"The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells","volume":"102","author":"Zhang","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jinf.2014.06.006_bib84","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1128\/IAI.00474-07","article-title":"Factor H binding to PspC of Streptococcus pneumoniae increases adherence to human cell lines in\u00a0vitro and enhances invasion of mouse lungs in\u00a0vivo","volume":"75","author":"Quin","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2014.06.006_bib85","doi-asserted-by":"crossref","first-page":"19427","DOI":"10.1074\/jbc.M109.003442","article-title":"Cdc42 and the phosphatidylinositol 3-kinase-Akt pathway are essential for PspC-mediated internalization of pneumococci by respiratory epithelial cells","volume":"284","author":"Agarwal","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jinf.2014.06.006_bib86","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.humimm.2010.10.007","article-title":"Modulation of human bronchial epithelial cells by pneumococcal choline binding protein A","volume":"72","author":"Cao","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib87","doi-asserted-by":"crossref","first-page":"e1003308","DOI":"10.1371\/journal.ppat.1003308","article-title":"Microbes bind complement inhibitor factor H via a common site","volume":"9","author":"Meri","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jinf.2014.06.006_bib88","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.molimm.2006.12.001","article-title":"The C-terminus of complement factor H is essential for host cell protection","volume":"44","author":"J\u00f3zsi","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib89","doi-asserted-by":"crossref","first-page":"15614","DOI":"10.1074\/jbc.M112.443507","article-title":"The choline-binding protein PspC of Streptococcus pneumoniae interacts with the C-terminal heparin-binding domain of vitronectin","volume":"288","author":"Voss","year":"2013","journal-title":"J Biol Chem"},{"issue":"Meeting Abstracts","key":"10.1016\/j.jinf.2014.06.006_bib90","article-title":"Confocal imaging and quantitative analysis of vitronectin expression by submucosal glands and surface epithelium of large airways","volume":"187","author":"Salazar-Pelaez","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib91","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1128\/IAI.01261-07","article-title":"Streptococcus pneumoniae choline-binding protein E interaction with plasminogen\/plasmin stimulates migration across the extracellular matrix","volume":"76","author":"Attali","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2014.06.006_bib92","doi-asserted-by":"crossref","first-page":"13017","DOI":"10.1523\/JNEUROSCI.2070-06.2006","article-title":"Cell-surface actin binds plasminogen and modulates neurotransmitter release from catecholaminergic cells","volume":"26","author":"Miles","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.jinf.2014.06.006_bib93","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ijmm.2013.06.002","article-title":"The interaction between bacterial enolase and plasminogen promotes adherence of Streptococcus pneumonia to epithelial and endothelial cells","volume":"303","author":"Bergmann","year":"2013","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.jinf.2014.06.006_bib94","doi-asserted-by":"crossref","first-page":"36272","DOI":"10.1074\/jbc.M807087200","article-title":"PfbA, a novel plasmin- and fibronectin-binding protein of Streptococcus pneumoniae, contributes to fibronectin-dependent adhesion and antiphagocytosis","volume":"283","author":"Yamaguchi","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jinf.2014.06.006_bib95","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijbiomac.2013.11.035","article-title":"Crystal structure of PfbA, a surface adhesin of Streptococcus pneumoniae, provides hints into its interaction with fibronectin","volume":"64","author":"Beulin","year":"2014","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jinf.2014.06.006_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2958.2010.07190.x","article-title":"Pneumococcal microbial surface components recognizing adhesive matrix molecules targeting of the extracellular matrix","volume":"77","author":"Paterson","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jinf.2014.06.006_bib97","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2041-1014.2009.00561.x","article-title":"Pneumococcal protein PavA is important for nasopharyngeal carriage and development of sepsis","volume":"25","author":"Kadioglu","year":"2010","journal-title":"Mol Oral Microbiol"},{"key":"10.1016\/j.jinf.2014.06.006_bib98","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.vaccine.2012.02.023","article-title":"Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans","volume":"30","author":"Khan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib99","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1128\/IAI.00562-13","article-title":"Surface association of Pht proteins of Streptococcus pneumoniae","volume":"81","author":"Plumptre","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2014.06.006_bib100","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2958.2009.06796.x","article-title":"The Streptococcus pneumoniae adhesin PsrP binds to keratin 10 on lung cells","volume":"73","author":"Shivshankar","year":"2009","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jinf.2014.06.006_bib101","doi-asserted-by":"crossref","first-page":"130090","DOI":"10.1098\/rsob.130090","article-title":"The basic keratin 10-binding domain of the virulence-associated pneumococcal serine-rich protein PsrP adopts a novel MSCRAMM fold","volume":"4","author":"Schulte","year":"2014","journal-title":"Open Biol"},{"key":"10.1016\/j.jinf.2014.06.006_bib102","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/CVI.00271-10","article-title":"PsrP, a protective pneumococcal antigen, is highly prevalent in children with pneumonia and is strongly associated with clonal type","volume":"17","author":"Mu\u00f1oz-Almagro","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib103","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.micinf.2012.06.007","article-title":"PcpA of Streptococcus pneumoniae mediates adherence to nasopharyngeal and lung epithelial cells and elicits functional antibodies in humans","volume":"14","author":"Khan","year":"2012","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jinf.2014.06.006_bib104","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2958.2007.05908.x","article-title":"RrgA is a pilus-associated adhesin in Streptococcus pneumoniae","volume":"66","author":"Nelson","year":"2007","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jinf.2014.06.006_bib105","doi-asserted-by":"crossref","first-page":"e1000026","DOI":"10.1371\/journal.ppat.1000026","article-title":"Pneumococcal pili are composed of protofilaments exposing adhesive clusters of Rrg A","volume":"4","author":"Hilleringmann","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jinf.2014.06.006_bib106","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1128\/JB.00384-08","article-title":"A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cells","volume":"190","author":"Bagnoli","year":"2008","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jinf.2014.06.006_bib107","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1073\/pnas.0511017103","article-title":"A pneumococcal pilus influences virulence and host inflammatory responses","volume":"103","author":"Barocchi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jinf.2014.06.006_bib108","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1128\/IAI.01400-06","article-title":"Streptococcus pneumoniae pilus subunits protect mice against lethal challenge","volume":"75","author":"Gianfaldoni","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2014.06.006_bib109","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.vaccine.2011.12.080","article-title":"Immunization with the RrgB321 fusion protein protects mice against both high and low pilus-expressing Streptococcus pneumoniae populations","volume":"30","author":"Moschioni","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib110","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1128\/CVI.00403-13","article-title":"Piliation of invasive Streptococcus pneumoniae isolates in the era before pneumococcal conjugate vaccine introduction in Malawi","volume":"20","author":"Kulohoma","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib111","doi-asserted-by":"crossref","first-page":"e1003473","DOI":"10.1371\/journal.ppat.1003473","article-title":"A type IV pilus mediates DNA binding during natural transformation in Streptococcus pneumoniae","volume":"9","author":"Laurenceau","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jinf.2014.06.006_bib112","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.2041-1014.2012.00658.x","article-title":"Pneumococcal neuraminidase A: an essential upper airway colonization factor for Streptococcus pneumoniae","volume":"27","author":"Brittan","year":"2012","journal-title":"Mol Oral Microbiol"},{"key":"10.1016\/j.jinf.2014.06.006_bib113","doi-asserted-by":"crossref","first-page":"e68647","DOI":"10.1371\/journal.pone.0068647","article-title":"Structural basis of the novel S. pneumoniae virulence factor, GHIP, a glycosyl hydrolase 25 participating in host-cell invasion","volume":"8","author":"Niu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2014.06.006_bib114","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/MMBR.65.2.187-207.2001","article-title":"Pneumococcal virulence factors: structure and function","volume":"65","author":"Jedrzejas","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.jinf.2014.06.006_bib115","doi-asserted-by":"crossref","first-page":"e61128","DOI":"10.1371\/journal.pone.0061128","article-title":"NADH oxidase functions as an adhesin in Streptococcus pneumoniae and elicits a protective immune response in mice","volume":"8","author":"Muchnik","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2014.06.006_bib116","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1074\/jbc.M112.405530","article-title":"Streptococcus pneumoniae endopeptidase O (PepO) is a multifunctional plasminogen- and fibronectin-binding protein, facilitating evasion of innate immunity and invasion of host cells","volume":"288","author":"Agarwal","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jinf.2014.06.006_bib117","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1471-2180-10-190","article-title":"New adhesin functions of surface-exposed pneumococcal proteins","volume":"10","author":"Frolet","year":"2010","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jinf.2014.06.006_bib118","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1099\/mic.0.28417-0","article-title":"Zinc metalloproteinase genes in clinical isolates of Streptococcus pneumoniae: association of the full array with a clonal cluster comprising serotypes 8 and 11A","volume":"152","author":"Camilli","year":"2006","journal-title":"Microbiology"},{"key":"10.1016\/j.jinf.2014.06.006_bib119","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1128\/IAI.00717-10","article-title":"Immunization with a ZmpB-based protein vaccine could protect against pneumococcal diseases in mice","volume":"79","author":"Gong","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2014.06.006_bib120","doi-asserted-by":"crossref","first-page":"e80062","DOI":"10.1371\/journal.pone.0080062","article-title":"Streptococcus pneumoniae serine protease HtrA, but not SFP or PrtA, is a major virulence factor in pneumonia","volume":"8","author":"de Stoppelaar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2014.06.006_bib121","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2174\/156652408785747924","article-title":"Pneumolysin: a double-edged sword during the host-pathogen interaction","volume":"8","author":"Marriott","year":"2008","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib122","doi-asserted-by":"crossref","first-page":"11018","DOI":"10.1074\/jbc.M111.318584","article-title":"LytA, major autolysin of Streptococcus pneumoniae, requires access to nascent peptidoglycan","volume":"287","author":"Mellroth","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jinf.2014.06.006_bib123","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1128\/JB.00114-12","article-title":"Export requirements of pneumolysin in Streptococcus pneumoniae","volume":"194","author":"Price","year":"2012","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jinf.2014.06.006_bib124","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/JB.01489-08","article-title":"Pneumolysin localizes to the cell wall of Streptococcus pneumoniae","volume":"191","author":"Price","year":"2009","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jinf.2014.06.006_bib125","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1097\/01.CCM.0000220496.48295.A9","article-title":"Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia","volume":"34","author":"Witzenrath","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib126","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1128\/IAI.00862-12","article-title":"Streptococcus pneumoniae capsular serotype invasiveness correlates with the degree of factor H binding and opsonization with C3b\/iC3b","volume":"81","author":"Hyams","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2014.06.006_bib127","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.4049\/jimmunol.176.7.4369","article-title":"Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection","volume":"176","author":"Suresh","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib128","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.4049\/jimmunol.1201967","article-title":"Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine","volume":"189","author":"Mukerji","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib129","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1128\/CVI.00393-12","article-title":"The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in\u00a0vitro","volume":"19","author":"Ren","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib130","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.4049\/jimmunol.0802376","article-title":"Clinical isolates of Streptococcus pneumoniae bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion","volume":"182","author":"Dieudonn\u00e9-Vatran","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib131","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.4049\/jimmunol.1102934","article-title":"Enolase of Streptococcus pneumoniae binds human complement inhibitor C4b-binding protein and contributes to complement evasion","volume":"189","author":"Agarwal","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib132","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1128\/IAI.68.7.3990-3997.2000","article-title":"Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract","volume":"68","author":"Pericone","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2014.06.006_bib133","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/rmed.2002.1316","article-title":"The effects of pneumolysin and hydrogen peroxide, alone and in combination, on human ciliated epithelium in\u00a0vitro","volume":"96","author":"Feldman","year":"2002","journal-title":"Respir Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib134","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/emmm.201202435","article-title":"Molecular architecture of Streptococcus pneumoniae surface thioredoxin-fold lipoproteins crucial for extracellular oxidative stress resistance and maintenance of virulence","volume":"5","author":"Saleh","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib135","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1128\/IAI.72.6.3584-3591.2004","article-title":"Role of HtrA in the virulence and competence of Streptococcus pneumoniae","volume":"72","author":"Ibrahim","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2014.06.006_bib136","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1016\/j.vaccine.2013.05.061","article-title":"Protection against pneumococcal infection elicited by immunization with multiple pneumococcal heat shock proteins","volume":"31","author":"Cao","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib137","doi-asserted-by":"crossref","first-page":"e77282","DOI":"10.1371\/journal.pone.0077282","article-title":"Streptococcus pneumoniae invades erythrocytes and utilizes them to evade human innate immunity","volume":"8","author":"Yamaguchi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2014.06.006_bib138","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1128\/IAI.72.9.5031-5040.2004","article-title":"PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected]","volume":"72","author":"Shaper","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2014.06.006_bib139","first-page":"1753","article-title":"Pneumococcal immune evasion: ZmpC inhibits neutrophil influx","volume":"15","author":"Surewaard","year":"2013","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.jinf.2014.06.006_bib140","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00281-013-0380-x","article-title":"Modulation of neutrophil NETosis: interplay between infectious agents and underlying host physiology","volume":"35","author":"Hahn","year":"2013","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jinf.2014.06.006_bib141","doi-asserted-by":"crossref","first-page":"10472","DOI":"10.1074\/jbc.M111.280321","article-title":"\u03b1-Enolase of Streptococcus pneumoniae induces formation of neutrophil extracellular traps","volume":"287","author":"Mori","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jinf.2014.06.006_bib142","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/IAI.01104-13","article-title":"Antibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media","volume":"82","author":"Short","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2014.06.006_bib143","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fimmu.2013.00056","article-title":"In\u00a0vivo and in\u00a0vitro studies on the roles of neutrophil extracellular traps during secondary pneumococcal pneumonia after primary pulmonary influenza infection","volume":"4","author":"Narayana Moorthy","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib144","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cub.2006.01.056","article-title":"An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps","volume":"16","author":"Beiter","year":"2006","journal-title":"Curr Biol"},{"key":"10.1016\/j.jinf.2014.06.006_bib145","doi-asserted-by":"crossref","first-page":"e32366","DOI":"10.1371\/journal.pone.0032366","article-title":"Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones","volume":"7","author":"Saffarzadeh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2014.06.006_bib146","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/mi.2013.41","article-title":"Pneumococcal IgA1 protease subverts specific protection by human IgA1","volume":"7","author":"Janoff","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib147","article-title":"Current status and perspectives on protein-based pneumococcal vaccines","author":"Darrieux","year":"2013","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.jinf.2014.06.006_bib148","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.vaccine.2013.06.105","article-title":"Design questions for Streptococcus pneumoniae vaccine trials with a colonisation endpoint","volume":"32","author":"Auranen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib149","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2249.2006.03148.x","article-title":"Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults","volume":"145","author":"Baril","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib150","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/CVI.00430-09","article-title":"Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection","volume":"17","author":"Moreno","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib151","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1086\/605023","article-title":"T cell memory response to pneumococcal protein antigens in an area of high pneumococcal carriage and disease","volume":"200","author":"Mureithi","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib152","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/IAI.00313-13","article-title":"CD4 T cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice","volume":"81","author":"Khan","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2014.06.006_bib153","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1016\/j.vaccine.2013.07.049","article-title":"A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA","volume":"31","author":"Frey","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib154","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1128\/IAI.00240-13","article-title":"Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae","volume":"81","author":"Kong","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2014.06.006_bib155","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.vaccine.2013.03.026","article-title":"Pneumococcal surface protein A does not affect the immune responses to a combined diphtheria tetanus and pertussis vaccine in mice","volume":"31","author":"Lima","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib156","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CVI.00754-12","article-title":"Conjugation of polysaccharide 6B from Streptococcus pneumoniae with pneumococcal surface protein A: PspA conformation and its effect on the immune response","volume":"20","author":"Perciani","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib157","doi-asserted-by":"crossref","first-page":"e59605","DOI":"10.1371\/journal.pone.0059605","article-title":"Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives","volume":"8","author":"Goulart","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2014.06.006_bib158","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1016\/j.vaccine.2012.10.076","article-title":"Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine","volume":"30","author":"Bologa","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib159","first-page":"93","article-title":"A multi-component pneumococcal protein vaccine is safe and immunogenic in a phase 1 randomized, placebo-controlled study","volume":"3","author":"Chang","year":"2014","journal-title":"Pneumonia"},{"key":"10.1016\/j.jinf.2014.06.006_bib160","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/infdis\/jit502","article-title":"Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein","volume":"209","author":"Mann","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib161","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2012.11.005","article-title":"Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults","volume":"31","author":"Kamtchoua","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib162","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1128\/CVI.00430-13","article-title":"Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults","volume":"21","author":"Berglund","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib163","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/IAI.00378-10","article-title":"Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens","volume":"79","author":"Godfroid","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2014.06.006_bib164","article-title":"Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials","author":"Leroux-Roels","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib165","doi-asserted-by":"crossref","first-page":"e78916","DOI":"10.1371\/journal.pone.0078916","article-title":"Vaccination against Streptococcus pneumoniae using truncated derivatives of polyhistidine triad protein D","volume":"8","author":"Plumptre","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2014.06.006_bib166","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/infdis\/jit481","article-title":"Intraclonal variations among Streptococcus pneumoniae isolates influence the likelihood of invasive disease in children","volume":"209","author":"Browall","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2014.06.006_bib167","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1099\/jmm.0.47661-0","article-title":"Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades","volume":"57","author":"Darrieux","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jinf.2014.06.006_bib168","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.vaccine.2010.12.074","article-title":"Selection of family 1 PspA molecules capable of inducing broad-ranging cross-reactivity by complement deposition and opsonophagocytosis by murine peritoneal cells","volume":"29","author":"Goulart","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib169","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1128\/IAI.01391-13","article-title":"Mucosal immunization with recombinant fusion protein DnaJ-\u0394A146Ply enhances cross-protective immunity against Streptococcus pneumoniae infection in mice via interleukin 17A","volume":"82","author":"Liu","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2014.06.006_bib170","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1586\/erv.12.5","article-title":"Issues and challenges in the development of pneumococcal protein vaccines: a two day international symposium","volume":"11","author":"Ginsburg","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jinf.2014.06.006_bib171","doi-asserted-by":"crossref","first-page":"e83798","DOI":"10.1371\/journal.pone.0083798","article-title":"Variation of pneumococcal pilus-1 expression results in vaccine escape during experimental otitis media [EOM]","volume":"9","author":"Figuera","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2014.06.006_bib172","series-title":"8th international symposium on pneumococci and pneumococcal diseases","article-title":"Identification of novel S. pneumoniae candidate vaccine antigens","author":"Mizrachi Nebenzahi","year":"2012"},{"key":"10.1016\/j.jinf.2014.06.006_bib173","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1007\/s12010-014-0749-x","article-title":"Identification of potential vaccine candidates against Streptococcus pneumoniae by reverse vaccinology approach","volume":"172","author":"Talukdar","year":"2014","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.jinf.2014.06.006_bib174","doi-asserted-by":"crossref","first-page":"e70365","DOI":"10.1371\/journal.pone.0070365","article-title":"Identification of potential new protein vaccine candidates through pan-surfomic analysis of pneumococcal clinical isolates from adults","volume":"8","author":"Olaya-Abril","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2014.06.006_bib175","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1016\/j.vaccine.2012.01.017","article-title":"High-throughput proteomic screening identifies Chlamydia trachomatis antigens that are capable of eliciting T cell and antibody responses that provide protection against vaginal challenge","volume":"30","author":"Picard","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib176","unstructured":"Hausdorff W, Godfroid F, Fierens F, Verlant V. Need for and development of a protein-based pneumococcal vaccine. http:\/\/www.meningitis.org.assets\/x\/53980."},{"key":"10.1016\/j.jinf.2014.06.006_bib177","first-page":"99","article-title":"Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2\u20134 years: phase II randomized study","volume":"3","author":"Odutola","year":"2014","journal-title":"Pneumonia"},{"key":"10.1016\/j.jinf.2014.06.006_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2014.03.066","article-title":"Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial","author":"Prymula","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2014.02.052","article-title":"Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I\/II randomized clinical study","author":"Leroux-Roels","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib180","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00807-13","article-title":"Randomized controlled study of pneumococcal vaccine formulations containing PhtD and dPly proteins with alum or adjuvant system AS02V in elderly adults: safety and immunogenicity","author":"Pauksens","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jinf.2014.06.006_bib181","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1016\/j.vaccine.2012.01.034","article-title":"Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine","volume":"30","author":"Moffitt","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib182","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.vaccine.2013.10.091","article-title":"Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability","volume":"32","author":"Gon\u00e7alves","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.06.006_bib183","first-page":"141","article-title":"A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media","volume":"6","author":"Rosch","year":"2014","journal-title":"EBMO Mol Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib184","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1164\/rccm.201212-2277OC","article-title":"Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults","volume":"187","author":"Ferreira","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2014.06.006_bib185","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1164\/rccm.201302-0361ED","article-title":"The potential of human nasal colonization with Streptococcus pneumoniae as a universal pneumococcal vaccine","volume":"187","author":"Gonzalez","year":"2013","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445314001662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445314001662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:19:34Z","timestamp":1759007974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445314001662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":185,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0163445314001662"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2014.06.006","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review: Current and new generation pneumococcal vaccines","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2014.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}